Media center
Press releases
-
April 3, 2008 - BDC Venture Capital and GO Capital invest in Alethia Biotherapeutics, a Montreal biotechnology firm
-
October 3, 2007 - Alethia Biotherapeutics Inc. announces in-licensing of family of monoclonal antibodies to treat metastatic cancer
-
March 12, 2007 - Alethia Biotherapeutics Inc. announces collaborative agreement with Biosite for antibody development in ovarian cancer
Copyright © 2002-2008 Alethia Biotherapeutics Inc. All rights reserved.